Logo
 
USD 917.17  CAD 1207.46  EUR 852.29  AUD 1207.72  GBP 734.79 
 

Browse Categories

Search Options

Search terms:

Listing type:

All  Fixed Price  Auction

Product type:

All  Digital  Physical

Price range:

USD  to USD

Origin country:

Ships to:

Order by:

Active vendor:

Automatic fulfillment:

Multisig options:

Bulk discounts:

In stock:

Payment type:

Cryptocurrency:

Average vendor processing:

Vendor trust level:

to

Exchange Rates

Bitcoin (BTC)

United States Dollar (USD)
917.17
 
Canadian Dollar (CAD)
1,207.46
 
Euro (EUR)
852.29
 
Australian Dollar (AUD)
1,207.72
 
British Pound (GBP)
734.79
 
Deposits & Withdrawals
 

Monero (XMR)

United States Dollar (USD)
11.63
 
Canadian Dollar (CAD)
15.31
 
Euro (EUR)
10.81
 
Australian Dollar (AUD)
15.31
 
British Pound (GBP)
9.32
 
Deposits & Withdrawals
 

The above rates are updated every 10 minutes and taken using a weighted average of major exchange platforms.

 

BLACKSTAR PHARMA - AROMASIN 50X25MG

BLACKSTAR PHARMA - AROMASIN 50X25MG Aromasin (Exemestane) is a steroidal Aromatase Inhibitor (AI) that is most commonly known as Aromasin. In fact, the Aromasin brand name is the only pharmaceutical grade brand of the Exemestane AI due to the tight patent Upjohn has maintained on the product. While tightly controlled by the pharmaceutical giant, Aromasin is available in numerous countries aroun...

Sold by Anabolic_Supplies - 42 sold since Jun 10, 2016  Vendor Level 4 Trust Level 5

 
Features
 
Product class
Physical package
 
Quantity left
Unlimited
 
Ends in
Never
 
 
Features
 
Origin country
United Kingdom
 
Ships to
Worldwide
 
Payment
Escrow
 
 

Purchase price: USD 43.23

Qty:  
0.0471 BTC / 3.7171 XMR

 

Product Description

BLACKSTAR PHARMA - AROMASIN 50X25MG

Aromasin (Exemestane) is a steroidal Aromatase Inhibitor (AI) that is most commonly known as Aromasin. In fact, the Aromasin brand name is the only pharmaceutical grade brand of the Exemestane AI due to the tight patent Upjohn has maintained on the product. While tightly controlled by the pharmaceutical giant, Aromasin is available in numerous countries around the globe.

Aromasin was first released on the U.S. market in 2000 after shortly gaining FDA approval a few months prior in 1999. The primary purpose of use as with most AI’s would be to combat breast cancer in post-menopausal women. Shortly after, the AI would begin to gain a lot of popularity among anabolic steroid users for its ability to protect against estrogenic related side effects. This action is very similar to the older and more popular AI’s in Arimidex (Anastrozole) and Femara (Letrozole). It would also gain a fair amount of popularity in Post Cycle Therapy (PCT) plans among steroid users. It was not the first AI to gain such popularity but would prove to be a little more advantageous for this purpose than most AI’s.
Recommended dose: 25 - 50mg per day

Duration: 4-8 weeks

aromasin nolvadex letrozole adex